Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Vasculitis
How do you approach the workup and management of isolated orbital inflammatory pseudotumor/granuloma?
No guidelines on isolated pseudotumour
Related Questions
When do you obtain nerve biopsy to evaluate for vasculitic neuropathy in patients with distal symmetric polyneuropathies?
How would you approach a patient with high CRP, rising liver enzymes and new biopsy proven liver granulomas 6 months after starting methotrexate and Rituximab therapy for ANCA vasculitis?
How do you approach confirming a diagnosis of limited GPA with nasal involvement vs relapsing polychondritis?
Would you consider re-dosing rituximab in a patient with ANCA vasculitis (early glomerulonephritis, pulmonary nodules, sinus symptoms) who experiences a flare of the disease and return of CD19 cells 3 months after initial rituximab administration?
How do you approach worsening memory loss in patients with GCA?
How do you treat IgA vasculitis with gastrointestinal involvement?
How would you approach failure of maintenance therapy (Azathioprine) for PR3 positive, c-ANCA positive, pulmonary–renal vasculitis previously induced with cyclophosphamide, with a history of anaphylaxis to rituximab?
How do you approach tapering of tocilizumab used for a history of GCA with vision loss?
Do you always pursue biopsy confirmation before diagnosing IgA vasculitis?
What is your approach to treating IgA nephropathy in patients who also have IgA vasculitis?